Previous research had revealed an increase in IP-10 levels after vaccinations (Tang et al., 2023), and the increase was evident in healthy individuals as well as in elderly or cancer patients after administration of the BNT162b2 vaccine (Konnova et al., 2022). The gene discussed is CXCL10; the disease is cancer.